Abstract:Abstract: Abstract:High-risk HPV infection accounts for 99.7% of cervical cancer, over 90% of anal cancer, 50% of head and neck cancers, 40% of vulvar cancer, and some cases of vaginal and penile cancer, contributing to approximately 5% of cancers worldwide. The development of cancer is a complex, multi-step process characterized by dysregulation of signaling pathways and alterations in metabolic pathways. Extensive research has demonstrated that metabolic reprogramming plays a key role in the progression of various cancers, such as cervical, head and neck, bladder, and prostate cancers, providing the material and energy foundation for rapid proliferation and migration of cancer cells. Metabolic reprogramming of tumor cells allows for the rapid generation of ATP, aiding in meeting the high energy demands of HPV-related cancer cell proliferation. The interaction between Human Papillomavirus (HPV) and its associated cancers has become a recent focus of investigation. The impact of HPV on cellular metabolism has emerged as an emerging research topic. A significant body of research has shown that HPV influences relevant metabolic signaling pathways, leading to cellular metabolic alterations. Exploring the underlying mechanisms may facilitate the discovery of biomarkers for diagnosis and treatment of HPV-associated diseases. In this review, we introduced the molecular structure of HPV and its replication process, discussed the diseases associated with HPV infection, described the energy metabolism of normal cells, highlighted the metabolic features of tumor cells, and provided an overview of recent advances in potential therapeutic targets that act on cellular metabolism. We discussed the potential mechanisms underlying these changes. This article aims to elucidate the role of Human Papillomavirus (HPV) in reshaping cellular metabolism and the application of metabolic changes in the research of related diseases. Targeting cancer metabolism may serve as an effective strategy to support traditional cancer treatments, as metabolic reprogramming is crucial for malignant transformation in cancer.

Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Toll-Like Receptors in Human Papillomavirus Infection

Role of Virus-Induced Host Cell Epigenetic Changes in Cancer

Relationship of Autophagy Genes and Human Papillomavirus Infection

Human tumor viruses: induction of three-dimensional alterations in the host genome structure

The Mechanism and Tumorigenesis of Oncogenic DNA Virus Integration

Virus-Driven Carcinogenesis

A review: cellular attachment and entry factors of human tumor-associated viruses

Regulation of Viral Oncogenesis by Micrornas

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability

Dynamic host immune response in virus-associated cancers

APOBEC-mediated Genomic Alterations Link Immunity and Viral Infection During Human Papillomavirus-Driven Cervical Carcinogenesis

Dysregulation of Host Cellular Genes Targeted by Human Papillomavirus (hpv) Integration Contributes to Hpv-Related Cervical Carcinogenesis

The Host Signaling Pathways Hijacked by Oncogenic Viruses

The Role of High Mobility Group AT-hook 1 in Viral Infections: Implications for Cancer Pathogenesis

HPV16 Integration Probably Contributes to Cervical Oncogenesis Through Interrupting Tumor Suppressor Genes and Inducing Chromosome Instability

The Epithelial-Mesenchymal Transition (Emt) Is Regulated By Oncoviruses In Cancer (Vol 30, Pg 3001, 2016)

HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins

Hijacked enhancer–promoter and silencer–promoter loops in cancer

Effect of HPV Oncoprotein on Carbohydrate and Lipid Metabolism in Tumor Cells